<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1231">
  <stage>Registered</stage>
  <submitdate>13/07/2006</submitdate>
  <approvaldate>13/07/2006</approvaldate>
  <nctid>NCT00352183</nctid>
  <trial_identification>
    <studytitle>Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy</studytitle>
    <scientifictitle>A Multicenter, Double-Blind, Randomized Study to Compare the Efficacy and Safety of the Combination of 145 mg Fenofibrate and 40 mg Simvastatin With 40 mg Simvastatin Monotherapy in Patients With Mixed Dyslipidemia at Risk of Cardiovascular Disease Not Adequately Controlled by 40 mg Simvastatin Alone.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>ACTRN012605000777695</secondaryid>
    <secondaryid>C LF0242780-01 05 02</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cardiovascular Diseases</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Fenofibrate/Simvastatin
Treatment: drugs - Simvastatin

Experimental: 1 - 

Active Comparator: 2 - 


Treatment: drugs: Fenofibrate/Simvastatin
Combination of Fenofibrate and Simvastatin 40mg

Treatment: drugs: Simvastatin
Simvastatin 40mg

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Triglycerides</outcome>
      <timepoint>12 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Percent change from baseline to 12 weeks of treatment in HDL-C</outcome>
      <timepoint>12 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Percent change from baseline to 12 weeks of treatment in LDL-C</outcome>
      <timepoint>12 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Percent change from baseline to 24 weeks of treatment in Triglycerides</outcome>
      <timepoint>24 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Percent change from baseline to 24 weeks of treatment in HDL-C</outcome>
      <timepoint>24 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Percent change from baseline to 24 weeks of treatment in LDL-C</outcome>
      <timepoint>24 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Mixed dyslipidemia</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Diabetes,

          -  Known hypersensitivity to fenofibrate or simvastatin,

          -  Pregnant or lactating women,

          -  Contra-indication to fenofibrate or simvastatin,

          -  Unstable or severe cardiac disease.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3 />
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2006</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>450</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/08/2008</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>Site 204 - Adelaide</hospital>
    <hospital>Site 214 - Adelaide</hospital>
    <hospital>Site 203 - Bendigo</hospital>
    <hospital>Site 207 - Brisbane</hospital>
    <hospital>Site 208 - Brisbane</hospital>
    <hospital>Site 221 - Brisbane</hospital>
    <hospital>Site 202 - Burnie</hospital>
    <hospital>Site 201 - Camperdown</hospital>
    <hospital>Site 220 - Coffs Harbour</hospital>
    <hospital>Site 218 - Daw Park</hospital>
    <hospital>Site 212 - Elizabeth Vale</hospital>
    <hospital>Site 217 - Fitzroy</hospital>
    <hospital>Site 222 - Fremantle</hospital>
    <hospital>Site 216 - Geelong</hospital>
    <hospital>Site 225 - Ingleburn</hospital>
    <hospital>Site 213 - Kippa-ring</hospital>
    <hospital>Site 209 - Launceston</hospital>
    <hospital>Site 219 - Liverpool</hospital>
    <hospital>Site 223 - Malvern</hospital>
    <hospital>Site 211 - Meadowbrook</hospital>
    <hospital>Site 224 - Miranda</hospital>
    <hospital>Site 210 - Nambour</hospital>
    <hospital>Site 205 - Parkville</hospital>
    <hospital>Site 206 - Sale</hospital>
    <hospital>Site 215 - Sydney</hospital>
    <postcode> - Adelaide</postcode>
    <postcode> - Bendigo</postcode>
    <postcode> - Brisbane</postcode>
    <postcode> - Burnie</postcode>
    <postcode> - Camperdown</postcode>
    <postcode> - Coffs Harbour</postcode>
    <postcode> - Daw Park</postcode>
    <postcode> - Elizabeth Vale</postcode>
    <postcode> - Fitzroy</postcode>
    <postcode> - Fremantle</postcode>
    <postcode> - Geelong</postcode>
    <postcode> - Ingleburn</postcode>
    <postcode> - Kippa-ring</postcode>
    <postcode> - Launceston</postcode>
    <postcode> - Liverpool</postcode>
    <postcode> - Malvern</postcode>
    <postcode> - Meadowbrook</postcode>
    <postcode> - Miranda</postcode>
    <postcode> - Nambour</postcode>
    <postcode> - Parkville</postcode>
    <postcode> - Sale</postcode>
    <postcode> - Sydney</postcode>
    <countryoutsideaustralia>
      <country>Estonia</country>
      <state>Tallinn</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Estonia</country>
      <state>Tartu</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Balatonfured</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Budapest</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Gyongyos</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Gyor</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Hodmezovasarhely</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Kecskemet</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Miskolc</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Sopron</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Szekesfehervar</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Latvia</country>
      <state>Daugavpils</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Latvia</country>
      <state>Jekabpils</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Latvia</country>
      <state>Ogre</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Latvia</country>
      <state>Riga</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Latvia</country>
      <state>Tukums</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Lithuania</country>
      <state>Alytus</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Lithuania</country>
      <state>Kaunas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Lithuania</country>
      <state>Klaipeda</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Lithuania</country>
      <state>Palanga</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Lithuania</country>
      <state>Siauliai</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Lithuania</country>
      <state>Vilnius</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Blenheim</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Christchurch</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Dunedin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Hamilton</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Hastings</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Nelson</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Newtown, Wellington</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Takapuna, Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Tauranga</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Solvay Pharmaceuticals</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Mixed or combined hyperlipidemia is a common metabolic disorder characterized by both
      hypercholesterolemia and hypertriglyceridemia. Statins and fibrates have complementary
      mechanisms and can be coadministered to patients with mixed hyperlipidemia. The overall
      objective of the study is to evaluate the efficacy and safety of combining fenofibrate and
      simvastatin in patients with mixed hyperlipidemia at risk of cardiovascular diseases.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00352183</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Global Clinical Director Solvay</name>
      <address>Solvay Pharmaceuticals</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>